ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
WC
West China Hospital, Sichuan University at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
West China Hospital, Sichuan University takes part in 20 sessions at ESMO 2026 in Madrid. Its program explores targeted and immune-based treatments across several cancers, alongside tumour testing. It covers neoadjuvant treatment approaches for upper urinary tract cancer and therapies for advanced bile duct and pancreatic cancers.
| Organization | ESMO 2026 Attendance |
|---|---|
WC West China Hospital, Sichuan University Chengdu, China | |
University hospital with a cancer center in Chengdu, China. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Integrated urine and plasma NGS profiling in patients with muscle-invasive bladder cancer undergoing bladder-preserving therapy Genitourinary cancersBiomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Biomarker analysis in the China cohort of the phase 3 TALAPRO-2 trial of first-line talazoparib (TALA) with enzalutamide (ENZA) in metastatic castration-resistant prostate cancer (mCRPC) Genitourinary cancersBiomarkers & precision oncology Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Homologous recombination repair variants of uncertain significance and clinical outcomes of standard therapy and PARP inhibition in prostate cancer: A real-world retrospective study Genitourinary cancersBiomarkers & precision oncology Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Abstract Sat Oct 24 10:55–11:00 Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Ivonescimab combined with dose-dense temozolomide in recurrent glioblastoma: Preliminary results of efficacy and safety from a single-arm, phase Ib/II trial Sarcoma, CNS, head & neck and rare cancers Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Nab-paclitaxel versus paclitaxel in neoadjuvant immunochemotherapy for resectable esophageal squamous cell carcinoma: An IPTW-adjusted multicentre cohort study Lung & thoracic cancersGastrointestinal cancers Poster Sun Oct 25 12:00–12:45 Renal dysfunction, plasma proteomic mediators and pan-cancer risk Biomarkers & precision oncology Poster Mon Oct 26 12:00–12:45 Poster Mon Oct 26 12:00–12:45 Updated results of a prospective, open-label study of surufatinib plus CAPTEM as conversion therapy for unresectable pancreatic neuroendocrine tumors Sarcoma, CNS, head & neck and rare cancers |
Find decision makers at West China Hospital, Sichuan University
Tell us what you sell and we’ll find the people at West China Hospital, Sichuan University most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction